Home/Hedge Fund Intelligence/Immix Biopharma, Inc.
Nasdaq: IMMXStockForm 13F30 Jun 2026

Hedge funds that hold Immix Biopharma, Inc. Nasdaq: IMMX

CUSIP 45258H106 · who reports it, how much, and how much it matters to them

18 of the 720 hedge fund managers we track reported shares of Immix Biopharma, Inc. (Nasdaq: IMMX) on Form 13F for 30 June 2026. Between them they reported USD 125m. The largest position belongs to Deep Track Capital, at USD 29m. The manager with the most riding on it is Great Point Partners, where it is 2.5% of the reported book.

Managers reporting it18of 720 we track
Value they reportUSD 125mshares only, 30 Jun 2026
Funds they run316with a file on PPLI.com
Largest positionUSD 29mDeep Track Capital
Typical weight0.0%median share of a manager's book
Heaviest weight2.5%Great Point Partners

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

18 managers, USD 125m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Immix Biopharma, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Deep Track Capital1 fund on PPLI.comUSD 29m0.4%
2Millennium Management6 funds on PPLI.comUSD 21m0.0%
3Marshall Wace LLP84 funds on PPLI.comUSD 19m0.0%
4Great Point Partners2 funds on PPLI.comUSD 13m2.5%
5Logos Global Management1 fund on PPLI.comUSD 10m0.4%
6Bleichroeder4 funds on PPLI.comUSD 10m1.8%
7Burkehill Global Management5 funds on PPLI.comUSD 5.6m0.2%
8Citadel Advisors32 funds on PPLI.comUSD 5.2m0.0%
9Balyasny Asset Management25 funds on PPLI.comUSD 4.3m0.0%
10Sphera Funds Management1 fund on PPLI.comUSD 2.8m0.4%
11J. Goldman & Co.1 fund on PPLI.comUSD 2m0.1%
12D. E. Shaw & Co.15 funds on PPLI.comUSD 960,0000.0%
13Squarepoint Ops7 funds on PPLI.comUSD 722,0000.0%
14Two Sigma Investments35 funds on PPLI.comUSD 414,0000.0%
15Engineers Gate Manager1 fund on PPLI.comUSD 184,0000.0%
16Scientech Research2 funds on PPLI.comUSD 139,0000.1%
17Magnetar Financial93 funds on PPLI.comUSD 113,0000.0%
18The Quarry1 fund on PPLI.comUSD 1,1550.0%
Next: where it matters most
Where it matters most

For Great Point Partners it is 2.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Great Point PartnersUSD 13m2.5%
2BleichroederUSD 10m1.8%
3Logos Global ManagementUSD 10m0.4%
4Deep Track CapitalUSD 29m0.4%
5Sphera Funds ManagementUSD 2.8m0.4%
6Burkehill Global ManagementUSD 5.6m0.2%
7Scientech ResearchUSD 139,0000.1%
8J. Goldman & Co.USD 2m0.1%
9Marshall Wace LLPUSD 19m0.0%
10Millennium ManagementUSD 21m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Immix Biopharma, Inc.

What is the ticker symbol of Immix Biopharma, Inc.?

Immix Biopharma, Inc. trades under the symbol IMMX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 45258H106.

Which hedge funds own Immix Biopharma, Inc. (Nasdaq: IMMX)?

18 of the 720 hedge fund managers PPLI.com tracks reported Immix Biopharma, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Deep Track Capital (USD 29m), Millennium Management (USD 21m), Marshall Wace LLP (USD 19m), Great Point Partners (USD 13m) and Logos Global Management (USD 10m).

How many hedge funds hold Immix Biopharma, Inc.?

18 managers in our coverage reported it, and between them they run 316 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Immix Biopharma, Inc.?

Great Point Partners, where the position was 2.5% of the reported 13F book at 30 June 2026.

Does this show who is short Immix Biopharma, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Immix Biopharma, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.